{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:35:41Z","timestamp":1780526141408,"version":"3.54.1"},"reference-count":17,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"\n Introduction<\/jats:title>\n Kawasaki disease (KD) is a serious pediatric systemic vasculitis that may cause cardiovascular complications, including coronary artery lesions (CAL). This study aimed to evaluate the predictive value of peripheral blood lymphocyte subsets for intravenous immunoglobulin (IVIG) treatment sensitivity in children with KD in Xinjiang.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This multicenter retrospective study collected clinical and laboratory data from 142 children with KD and 120 controls with infectious fever across several hospitals in Xinjiang from June 2022 to December 2024. Peripheral blood lymphocyte subsets and immunoglobulins were analyzed. Multivariate logistic regression was used to identify risk factors for IVIG non-responsiveness, and ROC curve analyses were performed to evaluate diagnostic efficacy.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Significant differences in lymphocyte subsets were observed between KD and control groups, including CD3+, CD4+, CD8+, CD19+, and the CD4+\/CD8+ ratio. Multivariate logistic regression identified CD4+ cell count as an independent risk factor for IVIG non-responsiveness. ROC analyses suggested that lymphocyte subsets and immunoglobulins (including CD3+, CD+, CD16+CD56+, IgA, and IgM) have diagnostic potential, with CD8+ and CD+ showing high sensitivity and specificity.<\/jats:p>\n <\/jats:sec>\n \n Discussion<\/jats:title>\n Peripheral blood lymphocyte subsets, particularly CD4+, may serve as useful biomarkers for predicting IVIG treatment response and distinguishing KD from other febrile illnesses. Further studies with larger sample sizes are warranted to refine predictive models and improve KD management.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fcvm.2025.1608572","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:44:14Z","timestamp":1767681854000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["A diagnostic prediction model was established based on the clinical characteristics of multicenter children with Kawasaki disease in Xinjiang"],"prefix":"10.3389","volume":"12","author":[{"given":"Muqing","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaotang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengling","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonglin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"B1","first-page":"1198","article-title":"Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)","volume":"25","year":"2023","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"B2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJM198608073150601","article-title":"The treatment of Kawasaki syndrome with intravenous gamma globulin","volume":"315","author":"Newburger","year":"1986","journal-title":"N Engl J Med"},{"key":"B3","first-page":"6","article-title":"The expert consensus on diagnosis and acute-phase treatment of Kawasaki disease","volume":"60","year":"2022","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"B4","first-page":"178","article-title":"Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children","volume":"16","author":"Kawasaki","year":"1967","journal-title":"Arerugi"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e015308","DOI":"10.1161\/JAHA.119.015308","article-title":"Corticosteroids added to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in high-risk patients with Kawasaki disease","volume":"9","author":"Ae","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0140-6736(18)32003-8","article-title":"Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial","volume":"393","author":"Hamada","year":"2019","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"112194","DOI":"10.1016\/j.intimp.2024.112194","article-title":"Development of an immunoinflammatory indicator-related dynamic nomogram based on machine learning for the prediction of intravenous immunoglobulin-resistant Kawasaki disease patients","volume":"134","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1002\/art.39939","article-title":"CD8+ T cells contribute to the development of coronary arteritis in the Lactobacillus casei cell wall extract-induced murine model of Kawasaki disease","volume":"69","author":"Noval Rivas","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"108396","DOI":"10.1016\/j.intimp.2021.108396","article-title":"Atlas of circulating immune cells in Kawasaki disease","volume":"102","author":"Xie","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3345\/kjp.2016.59.10.408","article-title":"Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment","volume":"59","author":"Seo","year":"2016","journal-title":"Korean J Pediatr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/archdischild-2017-314512","article-title":"Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing","volume":"104","author":"Yang","year":"2019","journal-title":"Arch Dis Child"},{"key":"B12","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1399-3038.2008.00779.x","article-title":"Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease","volume":"20","author":"Kuo","year":"2009","journal-title":"Pediatr Allergy Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12887-021-02876-w","article-title":"Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease","volume":"21","author":"Lu","year":"2021","journal-title":"BMC Pediatr"},{"key":"B14","doi-asserted-by":"publisher","first-page":"7927","DOI":"10.1038\/s41598-025-92277-1","article-title":"An interpretable machine learning-assisted diagnostic model for Kawasaki disease in children","volume":"15","author":"Duan","year":"2025","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","article-title":"Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association","volume":"135","author":"McCrindle","year":"2017","journal-title":"Circulation"},{"key":"B16","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1080\/03009742.2019.1604992","article-title":"Dynamics of immunocyte activation during intravenous immunoglobulin treatment in Kawasaki disease","volume":"48","author":"Matsuguma","year":"2019","journal-title":"Scand J Rheumatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15513815.2024.2414175","article-title":"Exploring causal correlations between inflammatory cytokines and Kawasaki disease: a Mendelian randomization","volume":"44","author":"Pan","year":"2024","journal-title":"Fetal Pediatr Pathol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1608572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:44:15Z","timestamp":1767681855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1608572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":17,"alternative-id":["10.3389\/fcvm.2025.1608572"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1608572","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"article-number":"1608572"}}